OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dapagliflozin delays renal fibrosis in diabetic kidney disease by inhibiting YAP/TAZ activation
Lan Feng, Yang Chen, Ni Li, et al.
Life Sciences (2023) Vol. 322, pp. 121671-121671
Closed Access | Times Cited: 15
Lan Feng, Yang Chen, Ni Li, et al.
Life Sciences (2023) Vol. 322, pp. 121671-121671
Closed Access | Times Cited: 15
Showing 15 citing articles:
Dapagliflozin improves diabetic kidney disease by inhibiting ferroptosis through β-hydroxybutyrate production
Yan Tian, Chenxia Zhou, Qun Yan, et al.
Renal Failure (2025) Vol. 47, Iss. 1
Open Access | Times Cited: 1
Yan Tian, Chenxia Zhou, Qun Yan, et al.
Renal Failure (2025) Vol. 47, Iss. 1
Open Access | Times Cited: 1
Emerging role of antidiabetic drugs in cardiorenal protection
Wen-Jia Fu, Jin-Ling Huo, Zi‐Hui Mao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Wen-Jia Fu, Jin-Ling Huo, Zi‐Hui Mao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
The roles of Hippo/YAP signaling pathway in physical therapy
Chunran Pan, Xiaoxia Hao, Xiaofeng Deng, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Chunran Pan, Xiaoxia Hao, Xiaofeng Deng, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Anti-Inflammatory Effects of SGLT2 Inhibitors: Focus on Macrophages
Elena Y. Rykova, Vadim V. Klimontov, Elena Kazakova, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1670-1670
Open Access
Elena Y. Rykova, Vadim V. Klimontov, Elena Kazakova, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1670-1670
Open Access
The critical role of the Hippo signaling pathway in renal fibrosis
Chenchen Zhao, Hongshuang Wang, Chang Xu, et al.
Cellular Signalling (2025), pp. 111661-111661
Closed Access
Chenchen Zhao, Hongshuang Wang, Chang Xu, et al.
Cellular Signalling (2025), pp. 111661-111661
Closed Access
Hippo signaling in acute kidney injury to chronic kidney disease transition: Current understandings and future targets
Tahib Habshi, Vishwadeep Shelke, Ajinath Kale, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 8, pp. 103649-103649
Closed Access | Times Cited: 11
Tahib Habshi, Vishwadeep Shelke, Ajinath Kale, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 8, pp. 103649-103649
Closed Access | Times Cited: 11
Unraveling Chronic Cardiovascular and Kidney Disorder through the Butterfly Effect
Dimitri Bedo, Thomas Beaudrey, Nans Florens
Diagnostics (2024) Vol. 14, Iss. 5, pp. 463-463
Open Access | Times Cited: 4
Dimitri Bedo, Thomas Beaudrey, Nans Florens
Diagnostics (2024) Vol. 14, Iss. 5, pp. 463-463
Open Access | Times Cited: 4
GRP78 Contributes to the Beneficial Effects of SGLT2 Inhibitor on Proximal Tubular Cells in DKD
Atsuko Nakatsuka, Satoshi Yamaguchi, Jun Wada
Diabetes (2024) Vol. 73, Iss. 5, pp. 763-779
Open Access | Times Cited: 3
Atsuko Nakatsuka, Satoshi Yamaguchi, Jun Wada
Diabetes (2024) Vol. 73, Iss. 5, pp. 763-779
Open Access | Times Cited: 3
Metabolic dysfunction−associated liver disease and diabetes: Matrix remodeling, fibrosis, and therapeutic implications
Weiguo Fan, Toby M. Bradford, Natalie J. Török
Annals of the New York Academy of Sciences (2024) Vol. 1538, Iss. 1, pp. 21-33
Closed Access | Times Cited: 3
Weiguo Fan, Toby M. Bradford, Natalie J. Török
Annals of the New York Academy of Sciences (2024) Vol. 1538, Iss. 1, pp. 21-33
Closed Access | Times Cited: 3
The Effect of Natural Polysaccharides in Treatment of Diabetic Nephropathy: A Review
Maohui Yang, R Chen, Xin Zhou, et al.
Starch - Stärke (2024) Vol. 76, Iss. 9-10
Closed Access | Times Cited: 2
Maohui Yang, R Chen, Xin Zhou, et al.
Starch - Stärke (2024) Vol. 76, Iss. 9-10
Closed Access | Times Cited: 2
A new perspective on proteinuria and drug therapy for diabetic kidney disease
Ruimin Zhang, Qian Wang, Yaqing Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Ruimin Zhang, Qian Wang, Yaqing Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Hippo/YAP signaling pathway: a new therapeutic target for diabetes mellitus and vascular complications
Lan Wei, Jingjing Gao, Liangzhi Wang, et al.
Therapeutic Advances in Endocrinology and Metabolism (2023) Vol. 14
Open Access | Times Cited: 5
Lan Wei, Jingjing Gao, Liangzhi Wang, et al.
Therapeutic Advances in Endocrinology and Metabolism (2023) Vol. 14
Open Access | Times Cited: 5
Understanding Proteinuria in Patients with Diabetic Kidney Disease and Progress of Drug Therapy from a New Perspective
Ruimin Zhang, Qian Wang, Xuefeng Zhou, et al.
(2023)
Open Access | Times Cited: 2
Ruimin Zhang, Qian Wang, Xuefeng Zhou, et al.
(2023)
Open Access | Times Cited: 2
Targeted delivery of type I TGF-β receptor-mimicking peptide to fibrotic kidney for improving kidney fibrosis therapy via enhancing the inhibition of TGF-β1/Smad and p38 MAPK pathways
Xiaohua Wang, Xiaohui Liu, Liming Xu, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112483-112483
Closed Access
Xiaohua Wang, Xiaohui Liu, Liming Xu, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112483-112483
Closed Access
Kidney single-cell transcriptomes uncover SGLT2i-induced metabolic reprogramming via restoring glycolysis and fatty acid oxidation
Ying Shi, Vivek Bhalla
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Ying Shi, Vivek Bhalla
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
